DCE-MRI for the Detection of Patients with Recurrent Prostate Cancer After Radiotherapy; a Matched Case-Control Study.

Maaike R. Moman¹, Greetje Groenendaal¹, Marco van Vulpen¹, Gijsbert H. Bol¹, Uulke A. van der Heide¹

The interpretation of DCE-MRI of the prostate can be difficult after radiotherapy, because of changes in microvasculature. This study demonstrates that DCE-MRI shows differences between patients with recurrent prostate cancer after radiotherapy, compared to matched control patients. These differences can be utilized for the detection of patients with recurrent prostate cancer in the follow-up after treatment.